The role of zinc in neurodegenerative inflammatory pathways in depression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 3, 2011, Pages 693-701

  Szewczyk, Bernadeta ^a   Kubera, Marta ^a   Nowak, Gabriel ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Depression; Inflammation; Neurodegeneration; Zinc

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; FLUOXETINE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; IMIPRAMINE; LITHIUM; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NERVE GROWTH FACTOR; NEUROTROPHIN 3; PAROXETINE; SEROTONIN; THYMULIN; ZINC;

BIPOLAR DEPRESSION; BORNA DISEASE; DEPRESSION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOREGULATION; INFLAMMATION; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN FUNCTION; RISK FACTOR; SHORT SURVEY; T LYMPHOCYTE; VIRUS INFECTION; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

ANIMALS; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS AS TOPIC; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; HUMANS; IMMUNE SYSTEM; INFLAMMATION; NERVE DEGENERATION; SEROTONIN; ZINC;

EID: 79954575692     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.02.010     Document Type: Short Survey

References (130)

1. Adachi M., Barrot M., Autry A.E., Theobald D., Monteggia M.L. Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry 2008, 63:642-649.
2. Albert M.J., Qadri F., Wahed M.A., Ahmed T., Rahman A.S., Ahmed F., et al. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine. J Infect Dis 2003, 187:909-913.
3. Bancila V., Nikonenko I., Dunant Y., Bloc A. Zinc inhibits glutamate release via activation of pre-synaptic K channels and reduces ischaemic damage in rat hippocampus. J Neurochem 2004, 90:1243-1250.
4. Barrondo S., Salles J. Allosteric modulation of 5-HT1A receptors by zinc: binding studies. Neuropharmacology 2009, 56:455-462.
5. Bobat R., Coovadia H., Stephen C., Naidoo K.L., McKerrow N., Black R.E., et al. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomized double-blind placebo-controlled trial. Lancet 2005, 366:1862-1867.
6. Bitanihirwe B.K.Y., Cunningham M.G. Zinc: the brain's dark horse. Synapse 2009, 63:1029-1049.
7. Bremmer M.A., Beekman A.T., Deeg D.J., Penninx B.W., Dik M.G., Hack C.E., et al. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 2008, 106:249-255.
8. Castren E., Voikar V., Rantamaki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 2007, 7:18-21.
9. Chen C.J., Liao S.L. Neurotrophic and neurotoxic effects of zinc on neonatal cortical neurons. Neurochem Int 2003, 42:471-479.
10. Chen N., Moshaver A., Raymond L.A. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition. Mol Pharmacol 1997, 51:1015-1023.
11. Christine C.W., Choi D.W. Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons. J Neurosci 1990, 10:108-116.
12. Cichy A., Sowa-Kućma M., Legutko B., Pomierny-Chamioło L., Siwek A., Piotrowska A., Szewczyk B., Poleszak E., Pilc A., Nowak G. Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors. Pharmacol Rep 2009, 61:1184-1191.
13. Cieslik K., Klen-Majewska B., Danilczuk Z., Wrobel A., Lupina T. Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats. Pharmacol Rep 2007, 59:46-52.
14. Cossack Z.T. T-lymphocyte dysfunction in the elderly associated with zinc deficiency and subnormal nucleoside phosphorylase activity: effect of zinc supplementation. Eur J Cancer Clin Oncol 1989, 25:973-976.
15. Cote A., Chiasson M., Peralta M.R., Lafortune K., Pellegrini L., Toth K. Cell type-specific action of seizure-induced intracellular zinc accumulation in the rat hippocampus. J Pysiol 2005, 566:821-837.
16. Corniola R.S., Tassabehji N.M., Hare J., Sharma G., Levenson C.W. Zinc deficiency impairs neuronal precursor cell proliferation and induces apoptosis via p53-mediated mechanisms. Brain Res 2008, 1237:52-61.
17. Cousins R.J., Liuzzi J.P., Lichten L.A. Mammalian zinc transport, trafficking, and signals. J Biol Chem 2006, 281:24085-24089.
18. Cunha M.P., Machado D.G., Bettio L.E., Capra J.C., Rodrigues A.L. Interaction of zinc with antidepressants in tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1913-1920.
19. Deloria-Knoll M., Steinhoff M., Semba R.D., Nelson K., Vlahov D., Meinert C.L. Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial. Vaccine 2006, 24:1670-1679.
20. Dietrich D.E., Bode L. Human Borna disease virus-infection and its therapy in affective disorders. APMIS Suppl 2008, 124:61-65.
21. Dietrich D.E., Bode L., Spannhuth C.W., Lau T., Huber T.J., Brodhun B., et al. Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial. Bipolar Disord 2000, 2:65-70.
22. Dwivedi Y., Mondal A.C., Rizavi H.S., Conley R.R. Suicide brain is associated with decreased expression of neurotrophins. Biol Psychiatry 2005, 58:315-324.
23. Duchateau J., Delepesse G., Vrijens R., Collet H. Beneficial effects of oral zinc supplementation on the immune response of old people. Am J Med 1981, 70:1001-1004.
24. Duman R.S. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 2004, 5:11-25.
25. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997, 54:597-606.
26. Ebadi M., Murrin L.C., Pfeiffer R.F. Hippocampal zinc thionein and pyridoxal phosphate modulate synaptic functions. Ann NY Acad Sci 1990, 585:189-201.
27. Eide D.J. Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta 2006, 1763:711-722.
28. Embi N., Rylatt D.B., Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 1980, 107:519-527.
29. Fedele E., Foster A.C. An evaluation of the role of extracellular amino acids in the delayed neurodegeneration induced by quinolinic acid in the rat striatum. Neuroscience 1993, 52:911-917.
30. Ferszt R., Severus E., Bode L., Brehm M., Kühl K.-P., Berzewski H., et al. Activated Borna disease virus in affective disorders. Pharmacopsychiatry 1999, 32:93-98.
31. Fischer Walker C., Black R.E. Zinc and the risk for infectious disease. Annu Rev Nutr 2004, 24:255-275.
32. Fraker P.J., Haas S., Luecke R.W. Effect of zinc deficiency on the immune response of the young adult A/J mouse. J Nutr 1977, 107:1889-1895.
33. Fraker P.J., DePasquale-Jardieu P., Zwicki C.M., Luecke R.W. Regeneration of T-cell helper function in zinc deficient adult mice. Proc Natl Acad Sci USA 1978, 75:5660-5664.
34. Franco J.L., Posser T., Brocardo P.S., Trevisan R., Uliano-Silva M., Gabilan N.H., et al. Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc. Behav Brain Res 2008, 188:316-323.
35. Frederickson C.J., Moncrieff D.W. Zinc-containing neurons. Biol Signals 1994, 3:127-139.
36. Frederickson C.J., Suh S.W., Silva D., Frederickson C.J., Thompson R.B. Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr 2000, 130:1471S-1483S.
37. Frost P., Rabbani P., Smith J., Prasad A.S. Cell mediated cytotoxicity and tumor growth in zinc deficient mice. Proc Soc Exp Biol Med 1981, 167:333-337.
38. Gao H.L., Zheng W., Na Xin, Chi Z.H., Wang Z.Y., Chen J., et al. Zinc deficiency reduces neurogenesis accompanied by neuronal apoptosis through caspase-dependent and -independent signaling pathways. Neurotox Res 2009, 16:416-425.
39. Giese K.P. GSK-3: a key player in neurodegeneration and memory. IUBMB Life 2009, 61:516-521.
40. Gould E., Gross C.G. Neurogenesis in adult mammals: some progress and problems. J Neurosci 2002, 22:619-623.
41. Gould T.D., Manji H.K. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 2005, 30:1223-1237.
42. Haase H., Overbeck S., Rink L. Zinc supplementation for the treatment or prevention of disease: current status and future perspectives. Exp Gerontol 2008, 43:394-408.
43. Hansen C.R., Malecha M., Mackenzie T.B., Kroll J. Copper and zinc deficiencies in association with depression and neurological findings. Biol Psychiatry 1983, 18:395-401.
44. Harrison N.L., Gibbons S.J. Zn2+: an endogenous modulator of ligand- and voltage-gated ion channels. Neuropharmacology 1994, 33:935-952.
45. Honscheid A., Rink L., Haase H. T-lymphocytes: a target for stimulatory and inhibitory effects of zinc ions. Endocr Metab Immune Disord Drug Targets 2009, 9:132-144.
46. Hoque K.M., Binder H.J. Zinc in the treatment of acute diarrhea: current status and assessment. Gastroenterology 2006, 130:2201-2205.
47. Howland J.G., Wang Y.T. Synaptic plasticity in learning and memory: stress effects in the hippocampus. Prog Brain Res 2008, 169:145-158.
48. Hulisz D. Efficacy of zinc against common cold viruses: an overview. J Am Pharm Assoc 2004, 44:594-603.
49. Ibs K.H., Rink L. Zinc-altered immune function. J Nutr 2003, 133:1452S-1456S.
50. Ilouz R., Kaidanovich O., Gurwitz D., Finkelman-Eldar H. Inhibition of glycogen synthase kinase-3β by divalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem Biophys Res Comm 2002, 295:102-106.
51. Jope R.S., Roh M.S. Glycogen synthase kinase-3 (GSK-3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 2006, 7:1421-1434.
52. Kaidanovich-Beilin O., Milman A., Weizman A., Pick C.G., Eldar-Finkelman H. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus. Biol Psychiatry 2004, 55:781-784.
53. Karlsen T.H., Sommerfelt H., Klomstad S., Andersen P.K., Strand T.A., Ulvik R.J., et al. Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole cell vaccine administered during zinc supplementation. Infect Immun 2003, 71:3909-3913.
54. Keller K.A., Grider A., Coffield J.A. Age-dependent influence of dietary zinc restriction on short-term memory in male rats. Physiol Behav 2001, 72:339-348.
55. Kitamura H., Morikawa H., Kamon H., Iguchi M., Hojyo S., Fukada T., et al. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat Immunol 2006, 7:971-977.
56. Kroczka B., Branski P., Palucha A., Pilc A., Nowak G. Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull 2001, 55:297-300.
57. Kroczka B., Ziȩba A., Dudek D., Pilc A., Nowak G. Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol J Pharmacol 2000, 52:403-406.
58. Kubera M., Van Bockstaele D., Maes M. Leukocyte subsets in treatment resistant major depression. Pol J Pharmacol 1999, 51:547-549.
59. Law W., Kelland E.E., Sharp P., Toms N.J. Characterization of zinc uptake into rat cultured cerebrocortical oligodendrocyte progenitor cells. Neurosci Lett 2003, 352:113-116.
60. Lee E., Son H. Adult hippocampal neurogenesis and related neurotrophic factors. BMB reports 2009, 42:239-244.
61. Liuzzi J.P., Cousins R.J. Mammalian zinc transporters. Annu Rev Nutr 2004, 24:151-172.
62. Maes M., Bosmans E., De Joungh R., Kenis G., Vandoolaeghe E., Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997, 9:853-858.
63. Maes M., D'Haese P.C., Scharpe S., D'Hondt P., Cosyns P., De Broe M.E. Hypozincemia in depression. J Affect Disord 1994, 31:135-140.
64. Maes M., DeMeester I., Verkerk R., Demedts P., Wauters A., Vanhoof G., et al. Lower serum dipeptidyl peptidase IV activity in treatment resistant depression: relationships with immune-inflammatory markers. Psychoneuroendocrinology 1997, 22:65-78.
65. Maes M., De Vos N., Demedts P., Wauters A., Neels H. Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J Affect Disord 1999, 56:189-194.
66. Maes M., Vandoolaeghe E., Neels H., Demedts P., Wauters A., Meltzer H.Y., et al. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 1997, 42:349-358.
67. Markovits P.M., Sankey A.W., James D.K., McCabe R., Mahomed K., Golding J. Zinc taste test and postnatal depression. Br J Psychiatry 1990, 156:451-452.
68. McLoughlin I.J., Hodge S.J. Zinc in depressive disorder. Acta Psychiatr Scand 1990, 82:451-453.
69. Mocchegiani E., Freddari C.B., Marcellini F., Malavota M. Brain, aging and neurodegeneration: role of zinc ion availability. Prog Neurobiol 2005, 75:367-390.
70. Muller N., Schwarz M.J. The immune-mediated alteration of serotonin and glutamate:towards an integrated view of depression. Mol Psychiatry 2007, 12:988-1000.
71. Myint A.M., Kim Y.K. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 2003, 61:519-525.
72. Narang R.L., Gupta K.R., Narang A.P., Singh R. Levels of copper and zinc in depression. Indian J Physiol Pharmacol 1991, 35:272-274.
73. Nowak G., Kubera M., Maes M. Neuroimmunological aspects of the alterations in zinc homeostasis in pathophysiology and treatment of depression. Acta Neuropsychiatr 2000, 12:49-53.
74. Nowak G., Legutko B., Szewczyk B., Papp M., Sanak M., Pilc A. Zinc treatment induces cortical brain-derived neurotrophic factor gene expression. Eur J Pharmacol 2004, 492:57-59.
75. Nowak G., Siwek M., Dudek D., Ziȩba A., Pilc A. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol 2003, 55:1143-1147.
76. Nowak G., Szewczyk B., Pilc A. Zinc and depression. An update. Pharmacol Rep 2005, 57:713-718.
77. Nowak G., Szewczyk B., Wieronska J.M., Branski P., Palucha A., Pilc A., et al. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull 2003, 61:159-164.
78. Nowak G., Ziȩba A., Dudek D., Krośniak M., Szymaczek M., Schlegel-Zawadzka M. Serum trace elements in animal models and human depression. Part I. Zinc. Hum Psychopharmacol Clin Exp 1999, 14:83-86.
79. Owe-Larsson B, Säll L, Salamon E, Allgulander C. HIV infection and psychiatric illness. Afr J Psychiatry (Johannesbg) 2009; 12: 115-28. Review.
80. Pang D., Syed S., Fine P., Jones P.B. No association between prenatal viral infection and depression in later life-a long-term cohort study of 6152 subjects. Can J Psychiatry 2009, 54:565-570.
81. Papavasiliou P.S., Miller S.T., Palat G., Pleban P., Mostek W. Selective disturbances of serum mineral profiles by electroconvulsive therapy. J Nerv Ment Dis 1985, 173:401-405.
82. Paoletti P., Ascher P., Neyton J. High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 1997, 17:5711-5725.
83. Paoletti P., Vergnano A.M., Barbour B., Casado M. Zinc at glutamatergic synapses. Neuroscience 2009, 158:126-136.
84. Pavuluri M.N., Smith M., Luk S.L. A neuroimmune hypothesis for the aetiopathology of viral illness and manic depression: a case report of an adolescent. J Affect Disord 1996, 39:7-11.
85. Pompeiano M., Palacios J.M., Mengod G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci 1992, 12:440-453.
86. Prasad A.S. Zinc: mechanisms of host defense. J Nutr 2007, 137:1-5.
87. Prasad A.S. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol 2008, 43:370-377.
88. Prasad A.S. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 2009, 12:646-652.
89. Prasad A.S., Fitzgerald J.T., Hess J.W., Kaplan J., Pelen F., Dardenne M. Zinc deficiency in elderly patients. Nutrition 1993, 9:218-224.
90. Qadri F., Ahmed T., Wahed M.A., Ahmed F., Bhuiyan N.A., Rahman A.S., et al. Suppressive effect of zinc on antibody response to cholera toxin in children given the killed, B subunit-whole cell, oral cholera vaccine. Vaccine 2004, 22:416-421.
91. Qian J., Noebels J.L. Visualization of transmitter release with zinc fluorescence detection at the mouse hippocampal mossy fibre synapse. J Physiol 2005, 566:747-758.
92. Rassendren F.A., Lory P., Pin J.P., Nargeot J. Zinc has opposite effects on NMDA and non-NMDA receptors expressed in Xenopus oocytes. Neuron 1990, 4:733-740.
93. Rimon R., Halonen P. Herpes simplex virus infection and depressive illness. Dis Nerv Syst 1969, 30:338-340.
94. Rink L., Haase H. Zinc homeostasis and immunity. TRENDS Immunol 2007, 28:1-4.
95. Rogóz Z., Skuza G., Daniel W.A., Wójcikowski J., Dudek D., Wróbel A. Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression. Pharmacol Rep 2007, 59:778-784.
96. Rosa A.O., Lin J., Calixto J.B., Santos A.R., Rodrigues A.L. Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res 2003, 144:87-93.
97. Rybakowski J.K., Amsterdam J.D. Lithium prophylaxis and recurrent labial herpes infections. Lithium 1991, 2:43-47.
98. Sakash J.B., Byme G.I., Lichtman A., Libby P. Cytokines induce indoleamine 2, 3-dioxygenase expression in human atheroma-associated cells: implication for persistent Chlamydophila pneumoniae infection. Infect Immun 2002, 70:3959-3961.
99. Schmidt H.D., Duman R.S. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 2007, 18:391-418.
100. Schlegel-Zawadzka M., Ziȩba A., Dudek D., Krośniak M., Szymaczek M., Nowak G. Effect of depression and of antidepressant therapy on serum zinc levels - a preliminary clinical study. Trace Elements in Man and Animals 10 2000, 607-610. Kluwer Academic Plenum Press, New York. A.M. Roussel, R.A. Anderson, A.E. Favrier (Eds.).
101. Schwarcz R., Whetsell W.O., mangano R.M. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 1983, 219:316-318.
102. Sen S., Sanacora G. Major depression: emerging therapeutics. MT Sinai J Med 2008, 75:204-225.
103. Sensi S.L., Paoletti P., Bush A.I., Sekler I. Zinc in the physiology and pathology of the CNS. Nat Rev Neurosci 2009, 10:780-791.
104. Seve M., Chimienti F., Devergnas S., Favier A. In silico identification and expression of SLC30 family genes: an expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expression. BMC Genom 2004, 5:32-36.
105. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003, 54:70-75.
106. Siwek M., Dudek D., Paul I.A., Sowa-Kućma M., Ziȩba A., Popik P., et al. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord 2008, 118:187-195.
107. Sluzewska A., Rybakowski J., Suwalska A. Viral reactivation in relation to immune activation in major depression. Eur Neuropsychopharmacol 1998, 8(Suppl. 2):S187-S188.
108. Smart T.G., Xie X., Krishek B.J. Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc. Prog Neurobiol 1994, 42:393-441.
109. 2+ ions: modulators of excitatory and inhibitory synaptic activity. Neuroscientist 2004, 10:432-442.
110. Sowa-Kućma M., Legutko B., Szewczyk B., Novak K., Znojek P., Poleszak E., et al. Antidepressant-activity of zinc: further behavioral and molecular evidence. J Neural Transm 2008, 115:1621-1628.
111. Sprietsma J.E. Cysteine, glutathione (GSH) and zinc and copper ions together are effective, natural, intracellular inhibitors of (AIDS) viruses. Med Hypotheses 1999, 52:529-538.
112. Suh S.W., Won S.J., Hamby A.M., Yoo B.H., Fan Y., Sheline C.T., et al. Decreased brain zinc availability reduces hippocampal neurogenesis in mice and rats. J Cereb Blood Flow Metab 2009, 29:1579-1588.
113. Szewczyk B., Branski P., Wieronska J.M., Palucha A., Pilc A., Nowak G. Interaction of zinc with antidepressants in the forced swimming test in mice. Pol J Pharmacol 2002, 54(6):681-685.
114. Szewczyk B., Poleszak E., Wlaz P., Wrobel A., Blicharska E., Cichy A., et al. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:323-329.
115. Takeda A. Movement of zinc and its functional significance in the brain. Brain Res Rev 2000, 34:137-148.
116. Takeda A., Kanno S., Sakurada N., Ando M., Oku N. Attenuation of hippocampal mossy fiber long-term potentiation of low micromolar concentrations of zinc. J Neurosci Res 2008, 86:2909-2911.
117. Takeda A., Minami A., Seki Y., Oku N. Differential effects of zinc on glutamatergic and GABAergic neurotransmitter systems in the hippocampus. J Neurosci Res 2004, 75:225-229.
118. Takeda A., Tamano H. Insight into zinc signaling from dietary zinc deficiency. Brain Res Rev 2009, 62:33-44.
119. Takeda A., Tamano H., Kan F., Hanajima T., Yamada K., Oku N. Enhancement of social isolation-induced aggressive behavior of young mice by zinc deficiency. Life Sci 2008, 82:909-914.
120. Takeda A., Tamano H., Tochigi M., Oku N. Zinc homeostasis in the hippocampus of zinc-deficient young adult rats. Neurochem Int 2005, 46:221-225.
121. Tassabehji N.M., Corniola R.S., Alshingiti A., Levenson C.W. Zinc deficiency induces depression-like symptoms in adult rats. Physiol Behav 2008, 95:365-369.
122. Van Kempen G.M., Goekoop J.G., de Wolff F.A. Plasma copper and zinc in psychiatric patients. Ned Tijdschr Geneeskd 1985, 129:550-553.
123. 2+ increases in apical dendrites of CA1 pyramidal neurons. Neuroscience 2009, 159:104-114.
124. Wang Z., Li J.Y., Dahlstrom A., Danscher G. Zinc-enriched GABAergic terminals in mouse spinal cord. Brain Res 2001, 921:165-172.
125. Wellinghausen N., Kirchner H., Rink L. The immunobiology of zinc. Immunol Today 1997, 18:519-521.
126. Whittle N., Lubec G., Singewald N. Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids 2009, 36:147-158.
127. Williams K. Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors. Neurosci Lett 1996, 215:9-12.
128. Wojcik J., Dudek D., Schlegiel-Zawadzka M., Grabowska M., Marcinek A., Florek E., et al. Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. Pharmacol Rep 2006, 58:571-576.
129. Zirpel L., Parks T.N. Zinc inhibition of group I mGluR-mediated calcium homeostasis in auditory neurons. JARO 2001, 2:180-187.
130. Zorzenon M., Colle R., Vecchio D., Bertoli M., Giavedoni A., Degrassi A., et al. Major depression, viral reactivation and immune system. Eur Psychiatr 1996, 11(Suppl. 4):S332-S333.